3 Recruiting Hematologic Malignancy Phase 2 Clinical Trials

Active phase 2 studies for hematologic malignancy enrolling across the USA. Verify eligibility and contact site coordinators.

All Hematologic Malignancy studies

Phase 2 Studies for Hematologic Malignancy

🔵 Active, Not Recruiting Phase2

Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation

📍 Weill Cornell Medical College — New York, New York

View Study & Checklist ➔

🟢 Recruiting Phase2

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

📍 University of Minnesota Masonic Cancer Center — Minneapolis, Minnesota

View Study & Checklist ➔

🟢 Recruiting Phase2

Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial

📍 The Ottawa Hospital - General Campus — Ottawa, Ontario

View Study & Checklist ➔